GL1X · GenesisL1 explorer

Research workbench

Discovery of small molecules binding to KRAS via high affinity antibody fragment competition method.

Analyse Discovery of small molecules binding to KRAS via high affinity antibody… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5OCG
Type
protein
Length
172 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
GTPase KRAS
UniProt
P01116
Ligands
GNP, 9R5, MG
Pockets
2 · best druggability 0.57

Structure

x-ray diffraction · 1 distinct chain · 40% helix, 26% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AGTPase KRASprotein17240% helix, 26% strandP01116

Ligands and binding sites

  • GNP · Phosphoaminophosphonic acid-guanylate ester · ligand · chains A
  • 9R5 · [(2~{R})-6-chloranyl-2,3-dihydro-1,4-benzodioxin-2-yl]methanamine · ligand · chains A
  • MG · Magnesium ion · metal · 2 copies · chains A
  • GOL · Glycerol · additive · chains A
  • PEG · Di(hydroxyethyl)ether · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11740.570.8130MG, GNP
2650.300.7514empty

Compared structures

  • 5OCG · Discovery of small molecules binding to KRAS via high affinity antibody fragment… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.